Physician

Barrett W Newsome, DO

According to 2025 Medicare claims, Barrett Newsome, DO (NPI: 1932293479) practices hematology/oncology in the Amherst Town-Northampton, MA market, with the plurality of this provider's patient population coming from Hampshire, MA. This provider's primary affiliated billing organization is MASS GENERAL BRIGHAM MEDICAL GROUP WESTERN MASSACHUSETTS INC (NPI: 1295787919; TIN: 043194547) and primary practice location at 01061-5001. Newsome is affiliated with the Mass General Brigham ACO, LLC (ACO ID: A4641), participating under the MSSP model.

Newsome's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 452 traditional Medicare patients, billed 2,147 HCPCS/CPT codes, and received $146,226 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 849 prescription claims across 160 beneficiaries totaling $6,601,642 in drug costs, led by Nubeqa (Darolutamide). DME data shows 108 claims. Open Payments data shows 5 records totaling $2,325. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $586,820 to $146,226. In contrast, Part D prescription costs have moved sharply higher in recent years, from $608,966 to $6,601,642. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	407	35,073	$586,820
2016	429	1,501	$102,326
2017	464	1,568	$104,377
2018	486	1,455	$101,559
2019	484	1,299	$89,460
2020	499	1,561	$101,442
2021	516	1,524	$126,296
2022	525	1,372	$115,233
2023	466	1,356	$109,456
2024	452	2,147	$146,226

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	85	429	$608,966
2016	123	662	$889,480
2017	157	1,098	$1,351,970
2018	168	1,057	$2,569,873
2019	128	650	$2,984,126
2020	122	644	$3,396,352
2021	116	537	$3,072,753
2022	133	592	$4,253,838
2023	158	778	$5,844,855
2024	160	849	$6,601,642

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	24	$6,176
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	23	$384
2023	N/R	58	$9,607
2024	N/R	108	$2,520

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	68	68	$167
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	136	298	$141
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	365	759	$93
99211	Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional	62	65	$18
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	308	765	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Nubeqa	Darolutamide	71	2,130	$898,360
Venclexta	Venetoclax	56	1,630	$667,363
Revlimid	Lenalidomide	40	1,120	$639,233
Lenalidomide	Lenalidomide	46	1,288	$581,289
Tagrisso	Osimertinib Mesylate	35	1,050	$574,417

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	33	$1,367
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	25	$471
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	27	$414
J8520	Capecitabine, oral, 150 mg	N	N/R	23	$269

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$2,325	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Barrett W. Newsome, DO?

Tedicare shows public-source Medicare data for Barrett W. Newsome, DO (NPI 1932293479), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Barrett W. Newsome, DO have ACO affiliation data?

Barrett W. Newsome, DO is shown with ACO affiliation data for Mass General Brigham ACO, LLC (MSSP, ACO ID A4641).

What billing organization is linked to Barrett W. Newsome, DO?

Barrett W. Newsome, DO is linked to MASS GENERAL BRIGHAM MEDICAL GROUP WESTERN MASSACHUSETTS INC (billing NPI 1295787919) in the available physician profile data.

Does Barrett W. Newsome, DO have Open Payments data?

Barrett W. Newsome, DO has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.